JACC: Advances - Nirmatrelvir-Ritonavir for Acute Covid-19 in Patients with Cardiovascular Disease and Post-Acute Sequelae of SARS-CoV-2-Infection

Release Date:

Commentary by Dr. Candice Silversides

JACC: Advances - Nirmatrelvir-Ritonavir for Acute Covid-19 in Patients with Cardiovascular Disease and Post-Acute Sequelae of SARS-CoV-2-Infection

Title
JACC: Advances - Nirmatrelvir-Ritonavir for Acute Covid-19 in Patients with Cardiovascular Disease and Post-Acute Sequelae of SARS-CoV-2-Infection
Copyright
Release Date

flashback